Joe Carlson | Star Tribune
Reporter | Medical technology

Joe Carlson writes about medical technology in Minnesota for the Star Tribune.

Carlson has covered health care beats full time since 2008, including medical technology, not-for-profit providers and health care legal affairs. His stories tend to blend health care business affairs and patient-focused information.


Glucose monitors, other device sales lift profit at Abbott Labs

While its medical device franchise is growing at a healthy rate overall, Abbott Laboratories is working quarter by quarter to unlock the growth potential of…


Hospital trade group wants Minn. to investigate Blue Cross Blue Shield

The insurer defended rules that the Minnesota Hospital Association said may violate state law.


John F. Hetterick, former PepsiCo and Rollerblade executive, dies at age 74

It was a baby shower unlike any other.Late last month, guests bearing baby gifts arrived at the Plymouth home of John and Kathe Hetterick, whose…


FDA recalls Medtronic 600-series MiniMed insulin pumps

Alert says Medtronic's MiniMed device could malfunction on airplanes.


Miromatrix spins out a company, steps up focus on bioengineered organs for humans

Reprise Biomedical will focus on device maker's hernia and wound-repair products.


SPR Therapeutics' neuromodulation system treats phantom-limb pain

Minnesota-made system has created long-lasting pain relief in trials.


Medtronic: Older insulin pumps are vulnerable to hackers

Medtronic is warning thousands of users worldwide that the devices may contain a serious cybersecurity vulnerability allowing a malicious hacker to change drug-delivery settings.


FDA releases millions of records of incidents involving medical devices

The previously undisclosed records were filed by device makers from 1999 to April.


FDA panel sees link between paclitaxel devices, patient death risk

Experts worry that its use for blocked leg arteries is linked to patient deaths.


After review of paclitaxel risks, FDA panel recommends more data

Seek more data to assess a rise in deaths and update product labels to reflect potential deaths, experts tell regulators after 2-day hearing.